Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Overview of the interleukin-1 family of ligands and receptors.

Dinarello CA.

Semin Immunol. 2013 Dec 15;25(6):389-93. doi: 10.1016/j.smim.2013.10.001. Epub 2013 Nov 23.

PMID:
24275600
2.

The interleukin-1 receptor family.

Boraschi D, Tagliabue A.

Semin Immunol. 2013 Dec 15;25(6):394-407. doi: 10.1016/j.smim.2013.10.023. Epub 2013 Nov 15. Review.

PMID:
24246227
3.

Immunological and inflammatory functions of the interleukin-1 family.

Dinarello CA.

Annu Rev Immunol. 2009;27:519-50. doi: 10.1146/annurev.immunol.021908.132612. Review.

PMID:
19302047
4.
5.

An expanding role for interleukin-1 blockade from gout to cancer.

Dinarello CA.

Mol Med. 2014 Dec 16;20 Suppl 1:S43-58. doi: 10.2119/molmed.2014.00232. Review.

6.
7.

The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence.

O'Neill L.

Biochem Soc Trans. 2000 Oct;28(5):557-63. Review.

PMID:
11044374
8.

The interleukin-1 receptor family.

Boraschi D, Tagliabue A.

Vitam Horm. 2006;74:229-54. Review.

PMID:
17027517
9.

The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.

O'Neill LA.

Immunol Rev. 2008 Dec;226:10-8. doi: 10.1111/j.1600-065X.2008.00701.x. Review.

PMID:
19161412
10.
11.

The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.

Palomo J, Dietrich D, Martin P, Palmer G, Gabay C.

Cytokine. 2015 Nov;76(1):25-37. doi: 10.1016/j.cyto.2015.06.017. Epub 2015 Jul 13. Review.

PMID:
26185894
12.

Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.

Yadav M, Zhang J, Fischer H, Huang W, Lutay N, Cirl C, Lum J, Miethke T, Svanborg C.

PLoS Pathog. 2010 Sep 23;6(9):e1001120. doi: 10.1371/journal.ppat.1001120.

13.

TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.

Garlanda C, Anders HJ, Mantovani A.

Trends Immunol. 2009 Sep;30(9):439-46. doi: 10.1016/j.it.2009.06.001. Epub 2009 Aug 21. Review.

PMID:
19699681
14.

Molecular interactions in interleukin and toll-like receptor signaling pathways.

Snyder GA, Sundberg EJ.

Curr Pharm Des. 2014;20(8):1244-58. Review.

PMID:
23713776
15.

Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.

Stoffels B, Hupa KJ, Snoek SA, van Bree S, Stein K, Schwandt T, Vilz TO, Lysson M, Veer CV, Kummer MP, Hornung V, Kalff JC, de Jonge WJ, Wehner S.

Gastroenterology. 2014 Jan;146(1):176-87.e1. doi: 10.1053/j.gastro.2013.09.030. Epub 2013 Sep 22.

PMID:
24067878
16.

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.

Horng T, Barton GM, Flavell RA, Medzhitov R.

Nature. 2002 Nov 21;420(6913):329-33.

PMID:
12447442
17.

Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.

Mantovani A, Locati M, Polentarutti N, Vecchi A, Garlanda C.

J Leukoc Biol. 2004 May;75(5):738-42. Epub 2003 Dec 12. Review.

PMID:
14673019
18.

SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.

Drexler SK, Kong P, Inglis J, Williams RO, Garlanda C, Mantovani A, Yazdi AS, Brennan F, Feldmann M, Foxwell BM.

Arthritis Rheum. 2010 Aug;62(8):2249-61. doi: 10.1002/art.27517.

19.

TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2.

Schwarz H, Posselt G, Wurm P, Ulbing M, Duschl A, Horejs-Hoeck J.

Immunobiology. 2013 Apr;218(4):533-42. doi: 10.1016/j.imbio.2012.06.007. Epub 2012 Jun 26.

PMID:
22795647
20.

IL-1 and IL-18 receptors, and their extended family.

Sims JE.

Curr Opin Immunol. 2002 Feb;14(1):117-22. Review.

PMID:
11790541

Supplemental Content

Support Center